Targeting thrombosis in exocrine pancreas cancer: A continued need for improved therapies Journal Article

  

Authors:	Epstein, A. S.; O'Reilly, E. M.
Article Title:	Targeting thrombosis in exocrine pancreas cancer: A continued need for improved therapies
Keywords:	antianemic agent; clinical feature; review; placebo; advanced cancer; cancer risk; nonhuman; systemic therapy; drug targeting; gemcitabine; pancreas cancer; pancreatic neoplasms; protein function; protein localization; disease association; risk factor; high risk patient; risk assessment; carcinogenesis; thrombosis; prophylaxis; cytokine production; anticoagulation; protein determination; primary prevention; plasminogen activator inhibitor 1; enoxaparin; low molecular weight heparin; thrombin; dalteparin; thrombomodulin; coumarin; thromboplastin; molecular pathology; thrombocyte factor 4; thrombosis prevention; antithrombin iii; blood clotting factor 7a inhibitor; tissue factor pathway inhibitor; pancreas, exocrine
Journal Title:	Expert Review of Anticancer Therapy
Volume:	11
Issue:	12
ISSN:	1473-7140
Publisher:	Taylor & Francis Group
Date Published:	2011-12-01
Start Page:	1783
End Page:	1785
Language:	English
DOI:	10.1586/era.11.183
PROVIDER:	scopus
PUBMED:	22117145
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-82355171771&partnerID=40&md5=ea106a1a983abb0ca83eaea12ee2bccd
Notes:	--- - "Export Date: 3 January 2012" - "CODEN: ERATB" - "Source: Scopus"

https://synapse.mskcc.org/synapse/works/has_related_data_chk/16383